Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Nesuparib | 2055357-64-5 | 99.5% | C23H24N6O | 50 MG
SDP

Catalog No. 5000355294
Encompass_Preferred

Nesuparib (JPI-547) is an orally active inhibitor for PARP 1/2 and Tankyrase 1/2. It inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1, and 2 nM, respectively. It demonstrates antitumor activity and is used in research of advanced solid tumors.

  • Orally active inhibitor for PARP 1/2 and Tankyrase 1/2
  • Inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1, and 2 nM
  • Demonstrates antitumor activity
  • Used in research of advanced solid tumors
  • Inhibits tankyrases, stabilizes AXIN protein, and impacts WNT/β-catenin and Hippo signaling pathways, leading to an antitumor effect
  • Shows promising antitumor activity against olaparib-resistant breast and ovary cancer in mouse xenograft models

Catalog No. 50-003-55294 Supplier Medchemexpress LLC Supplier No. HY14558450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nesuparib (JPI-547) is an orally active inhibitor for PARP 1/2 and Tankyrase 1/2. It inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1, and 2 nM, respectively. It demonstrates antitumor activity and is used in research of advanced solid tumors.

  • Orally active inhibitor for PARP 1/2 and Tankyrase 1/2
  • Inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1, and 2 nM
  • Demonstrates antitumor activity
  • Used in research of advanced solid tumors
  • Inhibits tankyrases, stabilizes AXIN protein, and impacts WNT/β-catenin and Hippo signaling pathways, leading to an antitumor effect
  • Shows promising antitumor activity against olaparib-resistant breast and ovary cancer in mouse xenograft models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.